Cargando…

Adding Weekly Intramuscular Progesterone to a Twice Daily Vaginal Progesterone Capsule for Luteal Phase Support in IVF/ICSI Cycles Results in Similar Live Birth Rates

OBJECTIVE: To compare pregnancy outcomes in patients undergoing artificial reproductive treatment (ART) and fresh embryo transfer (ET) who received twice-daily vaginal progesterone capsule (Cyclogest) alone verses twice daily vaginal progesterone capsule (Cyclogest) plus weekly intramuscular Hydroxy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gari, Salwa, Al-Jaroudi, Dania
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Brazilian Society of Assisted Reproduction 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769180/ https://www.ncbi.nlm.nih.gov/pubmed/34415122 http://dx.doi.org/10.5935/1518-0557.20210040

Ejemplares similares

Comparing intramuscular progesterone, vaginal progesterone and 17 -hydroxyprogestrone caproate in IVF and ICSI cycle
por: Moini, Ashraf, et al.
Publicado: (2011)

Vaginal micronized progesterone capsule versus vaginal progesterone gel for lutheal support in normoresponder IVF/ICSI-ET cycles
por: Sofuoglu, Kenan, et al.
Publicado: (2015)

Luteal phase bleeding after IVF cycles: comparison between progesterone vaginal gel and intramuscular progesterone and correlation with pregnancy outcomes
por: Jabara, Sami, et al.
Publicado: (2009)

Patients’ administration preferences: progesterone vaginal insert (Endometrin®) compared to intramuscular progesterone for Luteal phase support
por: Beltsos, Angeline N, et al.
Publicado: (2014)

Intramuscular progesterone (Gestone) versus vaginal progesterone suppository (Cyclogest) for luteal phase support in cycles of in vitro fertilization–embryo transfer: patient preference and drug efficacy
por: Zaman, Amal Yaseen, et al.
Publicado: (2017)

Luteal Phase Support in Intrauterine Insemination Cycles: A Randomized Clinical Trial of Vaginal Versus Intramuscular Progesterone Administration
por: Azargoon, Azam, et al.
Publicado: (2022)

Addition of intramuscular to vaginal progesterone for luteal phase support in fresh embryo transfer cycles: A cross-sectional study
por: Jalaliani, Samaneh, et al.
Publicado: (2022)

Progesterone for Luteal Phase Support in In Vitro Fertilization: Comparison of Vaginal and Rectal Pessaries to Vaginal Capsules: A Randomized Controlled Study
por: Khrouf, Mohamed, et al.
Publicado: (2017)

Subcutaneous progesterone versus vaginal progesterone for luteal phase support in in vitro fertilization: A retrospective analysis from daily clinical practice
por: Schütt, Marcel, et al.
Publicado: (2021)

Comparison of oral dydrogesterone with suppository vaginal progesterone for luteal-phase support in in vitro fertilization (IVF): A randomized clinical trial
por: Salehpour, Saghar, et al.
Publicado: (2013)

Do early luteal serum progesterone levels predict the reproductive outcomes in IVF with oral dydrogesterone for luteal phase support?
por: Netter, Antoine, et al.
Publicado: (2019)

Efficacy of dual progesterone administration (intramuscular and vaginal) for luteal support in fresh day 3 or day 4 embryo transfer cycles
por: Nho, Eun Jee, et al.
Publicado: (2020)

Progesterone signaling in the regulation of luteal steroidogenesis
por: Yakin, Kayhan, et al.
Publicado: (2023)

Dydrogesterone as an oral alternative to vaginal progesterone for IVF luteal phase support: A systematic review and individual participant data meta-analysis
por: Griesinger, Georg, et al.
Publicado: (2020)

Comparison of intravaginal progesterone gel and intramuscular 17-α-hydroxyprogesterone caproate in luteal phase support
por: SATIR, FUNDA, et al.
Publicado: (2013)

Subcutaneous progesterone versus vaginal progesterone for luteal-phase support in frozen-thawed embryo transfer: A cross-sectional study
por: Aflatoonian, Abbas, et al.
Publicado: (2021)

Co-administration of GnRH agonists with vaginal progesterone compared to vaginal progesterone in luteal phase support of the frozen-thawed embryo transfer cycle: An RCT
por: Zareii, Afsoon, et al.
Publicado: (2021)

The optimal duration of progesterone supplementation in pregnant women after IVF/ICSI: a meta-analysis
por: Liu, Xi-Ru, et al.
Publicado: (2012)

Progesterone Hypersensitivity: A Challenge for Luteal Support
por: Gupta, Astha, et al.
Publicado: (2018)

A randomized, controlled trial comparing the efficacy and safety of aqueous subcutaneous progesterone with vaginal progesterone for luteal phase support of in vitro fertilization
por: Baker, Valerie L., et al.
Publicado: (2014)

Efficacy, safety and tolerability of progesterone vaginal pessaries versus progesterone vaginal gel for luteal phase support after in vitro fertilisation: a randomised controlled trial
por: Saunders, Helen, et al.
Publicado: (2020)

Effects of intramuscular and vaginal progesterone supplementation on frozen-thawed embryo transfer
por: Jiang, Lei, et al.
Publicado: (2019)

Luteal Phase Support in assisted reproductive technology treatment: focus on Endometrin® (progesterone) vaginal insert
por: Check, Jerome H
Publicado: (2009)

Oral dydrogesterone vs. vaginal progesterone capsules for luteal-phase support in women undergoing embryo transfer: a systematic review and meta-analysis
por: Barbosa, Marina Wanderley Paes, et al.
Publicado: (2018)

The addition of dydrogesterone improves the outcomes of pregnant women with low progesterone levels when receiving vaginal progesterone alone as luteal support in HRT‐FET cycles
por: Toriumi, Rena, et al.
Publicado: (2023)

Intramuscular progesterone versus 8% Crinone vaginal gel for luteal phase support following blastocyst cryopreserved single embryo transfer: a retrospective cohort study
por: Bakkensen, Jennifer B., et al.
Publicado: (2020)

Oral dydrogesterone versus intravaginal micronized progesterone gel for luteal phase support in IVF: a randomized clinical trial
por: Griesinger, Georg, et al.
Publicado: (2018)

Comparison of intramuscular versus subcutaneous aqueous progesterone for luteal phase support in artificially prepared frozen embryo transfer cycles
por: Turgut, Emre Niyazi, et al.
Publicado: (2020)

A questionnaire-based audit to assess overall experience and convenience among patients using vaginal progesterone tablets (Lutigest(®)) for luteal phase support during IVF treatment
por: Heine, Polly, et al.
Publicado: (2017)

Exploration of the value of progesterone and progesterone/estradiol ratio on the hCG trigger day in predicting pregnancy outcomes of PCOS patients undergoing IVF/ICSI: a retrospective cohort study
por: Yang, Yiqing, et al.
Publicado: (2021)

Astaxanthin increases progesterone production in cultured bovine luteal cells
por: KAMADA, Hachiro, et al.
Publicado: (2017)

Mid-Luteal Progesterone Is Inversely Associated with Premenstrual Food Cravings
por: Hamidovic, Ajna, et al.
Publicado: (2023)

The effect of early administration of rectal progesterone in IVF/ICSI twin pregnancies on the preterm birth rate: a randomized trial
por: Aboulghar, Mona Mohamed, et al.
Publicado: (2020)

Subcutaneous Progesterone Is Effective and Safe for Luteal Phase Support in IVF: An Individual Patient Data Meta-Analysis of the Phase III Trials
por: Doblinger, Jakob, et al.
Publicado: (2016)

Comparison of Subcutaneous and Vaginal Progesterone Used for Luteal Phase Support in Patients Undergoing Intracytoplasmic Sperm Injection Cycles
por: Salehpour, Saghar, et al.
Publicado: (2021)

Effect of BMI on the value of serum progesterone to predict clinical pregnancy outcome in IVF/ICSI cycles: a retrospective cohort study
por: Shen, Zhaoyang, et al.
Publicado: (2023)

The effect of adding oral oestradiol to progesterone as luteal phase support in ART cycles – a randomized controlled study
por: Moini, Ashraf, et al.
Publicado: (2011)

Luteal Phase Support Using Subcutaneous Progesterone: A Systematic Review
por: Conforti, Alessandro, et al.
Publicado: (2021)

Correction to “Notification: Prevention of preterm birth: a randomized trial of vaginal compared with intramuscular progesterone”
Publicado: (2023)

Clinical Re-evaluation on Bioequivalence and Relative Bioavailability of Micronized Progesterone Hard Capsule (Yimaxin) and Micronized Progesterone Soft Capsule (Utrogestan) under Vaginal and Oral Administration Routes
por: Wang, Hanbi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ettn0k4uuoeesssvsg7m8i2842